1,292
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Antipsychotic treatment: experiences of fully recovered service users

, , , , , , , , & show all
Pages 264-270 | Received 19 May 2016, Accepted 01 Feb 2017, Published online: 01 Mar 2017

References

  • Adams CE, Bergman H, Irving CB, Lawrie S. (2013). Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev, (11), CD003082. doi: 10.1002/14651858.CD003082.pub3
  • Andreasen NC. (2006). Standardized remission criteria in schizophrenia. Acta Psychiatr Scand, 113, 81
  • Andreasen NC, Carpenter WT Jr, Kane JM, et al. (2005). Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry, 162, 441–449
  • APA. ( 2006). American Psychiatric Association. Practice Guidelines for the treatment of psychiatric disorders: Compendium. Arlington (VA): American Psychiatric Pub
  • Beck R, Heffernan S, Law H, et al. (2012). Subjective judgements of perceived recovery from psychosis. J Ment Health, 21, 556–566
  • Bellack AS, Green MF, Cook JA, et al. (2007). Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop. Schizophr Bull, 33, 805–822
  • Bola JR, Kao DT, Soydan H. (2011). Antipsychotic medication for early-episode schizophrenia. Schizophr Bull, 38, sbr167
  • Borg M, Kristiansen K. (2004). Recovery-oriented professionals: Helping relationships in mental health services. J Ment Health, 13, 493–505
  • Boyatzis RE. (1998). Transforming qualitative information: Thematic analysis and code development. London, UK: Sage
  • Braun V, Clarke V. (2006). Using tematic analysis in psychology. Qual Res Psychol, 3, 77–101
  • Davidson L, Schmutte T, Dinzeo T, Andres-Hyman R. (2008). Remission and recovery in schizophrenia: Practitioner and patient perspectives. Schizophr Bull, 34, 5–8
  • Davidson L, Stayner DA, Nickou C, et al. (2001). “Simply to be let in”: Inclusion as a basis for recovery. Psychiatr Rehabil J, 24, 375
  • Dixon LB, Holoshitz Y, Nossel I. (2016). Treatment engagement of individuals experiencing mental illness: Review and update. World Psychiatr, 15, 13–20
  • First M, Spitzer R, Gibbon M, Williams JB. (1995). Structured clinical interview for DSM-IV Axis I disorders (SCID). New York: New York State Psychiatric Institute, Biometrics Research
  • Fossey E, Harvey C, McDermott F, Davidson L. (2002). Understanding and evaluating qualitative research. Aust N Z J Psychiatry, 36, 717–732
  • Gadamer H. (1989). Truth and method. London: Sheed & Ward
  • Hamilton S, Lewis-Holmes E, Pinfold V, et al. (2014). Discrimination against people with a mental health diagnosis: Qualitative analysis of reported experiences. J Ment Health, 23, 88–93
  • Harrow M, Jobe TH. (2013). Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Schizophr Bull, 39, 962–965
  • Hegelstad W, Larsen T, Auestad B, et al. (2012). Long-term follow-up of the TIPS early detection in psychosis study: Effects on 10-year outcome. Am J Psychiatr, 169, 374
  • Heidegger M. (1996). Being and time: A translation of Sein und Zeit. Albany: SUNY Press
  • Hill CE, Thompson BJ, Williams EN. (1997). A guide to conducting consensual qualitative research. Couns Psychol, 25, 517–572
  • Joa I, Johannessen JO, Auestad B, et al. (2008). The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull, 34, 466–472
  • Jaaskelainen E, Juola P, Hirvonen N, et al. (2013). A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull, 39, 1296–1306
  • Kay SR, Fiszbein A, Opler LA. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull, 13, 261–276
  • Kleim B, Vauth R, Adam G, et al. (2008). Perceived stigma predicts low self-efficacy and poor coping in schizophrenia. J Ment Health, 17, 482–491
  • Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. (2010). The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2009. Schizophr Bull, 36, 94–103
  • Leamy M, Bird V, Le Boutillier C, et al. (2011). Conceptual framework for personal recovery in mental health: Systematic review and narrative synthesis. Brit J Psychiatr, 199, 445–452
  • Lehman AF. (1996). Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol, 31, 78–88
  • Leucht S, Hierl S, Kissling W, et al. (2012a). Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Brit J Psychiatr, 200, 97–106
  • Leucht S, Tardy M, Komossa K, et al. (2012b). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev, (5), CD008016. doi: 10.1002/14651858.CD008016.pub2
  • Liberman R, Kopelowicz A. (2002). Recovery from schizophrenia: A challenge for the 21st century. Int Rev Psychiatr, 14, 245–255
  • MacDonald E, Sauer K, Howie L, Albiston D. (2005). What happens to social relationships in early psychosis? A phenomenological study of young people's experiences. J Ment Health, 14, 129–143
  • Miles MB, Huberman AM, Saldaña J. (2013). Qualitative data analysis: A methods sourcebook. Thousand Oaks (CA): SAGE Publications, Incorporated
  • Moncrieff J. (2015). Antipsychotic maintenance treatment: Time to rethink? PLoS Med, 12, e1001861
  • Murray RM, Quattrone D, Natesan S, et al. (2016). Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? Br J Psychiatry, 209, 361–365
  • NICE. (2014). National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: Prevention and management [CG178]. N. C. C. f. M. Health, 58
  • Perkins DO, Johnson JL, Hamer RM, et al. (2006). Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res, 83, 53–63
  • Pope C, Ziebland S, Mays N. (2000). Qualitative research in health care. Analysing qualitative data. BMJ, 320, 114–116
  • Saha K, Bo L, Zhao S, et al. (2016). Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev, (4), CD010631. doi: 10.1002/14651858.CD010631.pub2
  • Sohler N, Adams B, Barnes D, et al. (2016). Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review. Am J Orthopsychiatr, 86, 477–485
  • Stain HJ, Brønnick K, Hegelstad WT, et al. (2013). Impact of interpersonal trauma on the social functioning of adults with first-episode psychosis. Schizophr Bull, 40, 1491–1498
  • Strauss JS, Carpenter WT. Jr (1977). Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry, 34, 159–163
  • WHO. (1996). Guidelines for ATC classification and DDD assignment Guidelines for ATC classification and DDD assignment. World Health Organization
  • Windell D, Norman R, Malla AK. (2012). The personal meaning of recovery among individuals treated for a first episode of psychosis. Psych Serv, 63, 548–553
  • Windell DL, Norman R, Lal S, Malla A. (2015). Subjective experiences of illness recovery in individuals treated for first-episode psychosis. Soc Psychiatry Psychiatric Epidemiol, 50, 1069–1077
  • Wunderink L, Nieboer RM, Wiersma D, et al. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70, 913–920

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.